|
INTERVIEW QUESTIONS
ACCOUNTS
GENERAL LEDGER
DETAILS
Question: <div class="boardReadBody"> RU-486, the first trade name for <a href="https://gynq.net" title="미프진">미프진</a>, a synthetic steroid preparation prescribed for induction of abortion in early pregnancy. The name is derived from the abbreviation and serial number of Roussel-Uclaf Pharmaceuticals. The RU-486 was approved for use in France in 1988 and almost immediately became the subject of passionate opposition by rights groups and homosexual advocacy by rights groups of abortions. Both sides understood that as the RU-486 is rapidly being called, abortion contraceptives can change the dynamics of abortion, making women relatively easy and privacy, in most cases without medical complications and ending early pregnancy. Invasive Surgery Procedures In 1995, an executive at Roussel-Uclaf formed a company called Exelgyn to obtain a patent. Approved for use in the UK in 1991, Mifegyne in Germany in 1999, and Mifeprex in the United States in 2000. </div> <div class="boardReadFooter">
Answer: No answer available currently.
|
|
|
Category |
General Ledger Interview Questions & Answers -
Exam Mode /
Learning Mode
|
Rating |
(0.2) By 1360 users |
Added on |
4/25/2020 |
Views |
10084 |
Rate it! |
|
|
Question:
<div class="boardReadBody"> RU-486, the first trade name for <a href="https://gynq.net" title="미프진">미프진</a>, a synthetic steroid preparation prescribed for induction of abortion in early pregnancy. The name is derived from the abbreviation and serial number of Roussel-Uclaf Pharmaceuticals. The RU-486 was approved for use in France in 1988 and almost immediately became the subject of passionate opposition by rights groups and homosexual advocacy by rights groups of abortions. Both sides understood that as the RU-486 is rapidly being called, abortion contraceptives can change the dynamics of abortion, making women relatively easy and privacy, in most cases without medical complications and ending early pregnancy. Invasive Surgery Procedures In 1995, an executive at Roussel-Uclaf formed a company called Exelgyn to obtain a patent. Approved for use in the UK in 1991, Mifegyne in Germany in 1999, and Mifeprex in the United States in 2000. </div> <div class="boardReadFooter">
Answer:
No answer available currently. Be the first one to reply to this question by submitting your answer from the form below.
If you have the better answer, then send it to us. We will display your answer after the approval.
Rules to Post Answers in CoolInterview.com:-
- There should not be any Spelling Mistakes.
- There should not be any Gramatical Errors.
- Answers must not contain any bad words.
- Answers should not be the repeat of same answer, already approved.
- Answer should be complete in itself.
|
|
Related Questions |
View Answer |
Please Note: We keep on updating better answers to this site. In case you are looking for Jobs, Pls Click Here Vyoms.com - Best Freshers & Experienced Jobs Website.
View All General Ledger Interview Questions & Answers - Exam Mode /
Learning Mode
|